Breast Cancer Episode 21: Neoadjuvant immunotherapy for high-risk ER+/HER2- breast cancer: insights from the CheckMate-7FL trial 28 March 2024
GI Episode 12: The RATIONALE-306 study solidifies checkpoint inhibition therapy in ESCC 27 March 2024
GUUrothelial cancer Episode 10: Enhancing neoadjuvant chemotherapy with immune checkpoint inhibition in MIBC: insights from the NEMIO Trial 25 March 2024
Breast Cancer Episode 20: Primary results from the TROPION-Breast01 study on Dato-DXd in HR+/HER2- metastatic breast cancer treatment 21 March 2024
GI Episode 11: Sotorasib plus panitumumab increases PFS in metastatic KRAS G12C mutated colorectal cancer patients: CodeBreak 300 20 March 2024
Lung Cancer Episode 8: The LIBRETTO-431 trial demonstrates the efficacy of selpercatinib in RET fusion-positive NSCLC 19 March 2024
GUUrothelial cancer Episode 9: Double ADC treatment as a promising approach in mUC: a dose-response trial 18 March 2024
Breast Cancer Episode 19: Efficacy of ADC therapy in HER2 low breast cancer: updated results from DESTINY-Breast04 14 March 2024
GI Episode 10: MOUNTAINEER-02 introducing TUC with Tras as a new standard for HER2+ RAS WT mCRC patients 13 March 2024
Lung Cancer Episode 7: AEGEAN study results confirm ctDNA as a predictive biomarker for pCR in NSCLC patients with neoadjuvant treatment 12 March 2024
